RM

Roshan Masih

Active Director Director DIN 08746251
DIN 08746251 First appointment May 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2020
Shareholding value •••• Premium profile

About Roshan Masih

Data last updated:

Roshan Masih is a Director at Medzonics (Opc) Private Limited (since 2020). The company operates in Healthcare. Medzonics (Opc) Private Limited reported revenue of ₹52,181 (FY 2025).

DIN 08746251
Primary Designation Director
Industry Healthcare
First Appointment 23 May 2020
Oldest Company Age 6 yrs
Largest company Medzonics (Opc) Private Limited · ₹52,181 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medzonics (Opc) Private Limited U85100HR2020OPC086353
Director23 May 20202020₹52,181 (FY 2025)Active

Board colleagues of Roshan Masih

NameDINCompanyDesignation
Shet Masih06416262Medzonics (Opc) Private LimitedNominee

Directorship timeline

Open interactive timeline →
Medzonics (Opc) Private Limited
Premium access

Shareholding and investment profile for Roshan Masih

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roshan Masih

Roshan Masih currently holds 1 directorship: Medzonics (Opc) Private Limited (Director, since 23 May 2020, revenue ₹52,181 (FY 2025)).

Roshan Masih was first appointed on 23 May 2020 as Director at Medzonics (Opc) Private Limited.

The current boards of Roshan Masih's companies include Shet Masih (Medzonics (Opc) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available